About Biomedical Innovation

The objective of the MIT CBI BioMANufacturing Research Program is to develop new knowledge, science, technologies and strategies that advance the manufacture and global delivery of high quality biopharmaceuticals. Bioman leverages MIT research in both engineering and science to advance new technologies for bioprocessing from high throughput platforms for speeding clonal selection and validated micro-bioreactors to novel sensors and new formulations

website icon
Website
employees icon
Employees
industry icon
Industry
Medical Practices
location icon
Headquarter
Cambridge, MA
description icon
Founded
Unkn

Biomedical Innovation Alternatives

Frequently Asked Questions about Biomedical Innovation

Who are the decision makers in Biomedical Innovation?

The decision makers in Biomedical Innovation are Elliott Antman, Elliott Antman, Erin Mckenna, etc. Click to Find Biomedical Innovation decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more